F. C. Breedveld

14.1k total citations · 3 hit papers
119 papers, 10.2k citations indexed

About

F. C. Breedveld is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, F. C. Breedveld has authored 119 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Rheumatology, 35 papers in Radiology, Nuclear Medicine and Imaging and 30 papers in Hematology. Recurrent topics in F. C. Breedveld's work include Rheumatoid Arthritis Research and Therapies (68 papers), Systemic Lupus Erythematosus Research (35 papers) and Monoclonal and Polyclonal Antibodies Research (33 papers). F. C. Breedveld is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (68 papers), Systemic Lupus Erythematosus Research (35 papers) and Monoclonal and Polyclonal Antibodies Research (33 papers). F. C. Breedveld collaborates with scholars based in Netherlands, United States and Austria. F. C. Breedveld's co-authors include Josef S Smolen, Joachim R. Kalden, Ravinder N. Maini, Ben A. C. Dijkmans, Christian Antoni, T. Huizinga, D. van Zeben, Cornelia F Allaart, Jeska K de Vries‐Bouwstra and Y P M Goekoop-Ruiterman and has published in prestigious journals such as The Lancet, The Journal of Immunology and Neurology.

In The Last Decade

F. C. Breedveld

117 papers receiving 9.7k citations

Hit Papers

Randomised double-blind comparison of chimeric monoclonal... 1994 2026 2004 2015 1994 2005 2006 400 800 1.2k

Peers

F. C. Breedveld
Comparison fields: 5 of 147
  • Rheumatology 6.9k
  • Hematology 2.5k
  • Immunology 2.2k
  • Radiology, Nuclear Medicine and Imaging 1.5k
  • Pathology and Forensic Medicine 1.1k
Replace M. A. van Leeuwen with:
M. A. van Leeuwen Netherlands
L.B.A. van de Putte Netherlands
Joachim R. Kalden Germany
Carlomaurizio Montecucco Italy
Arthur Kavanaugh United States
James R. O’Dell United States
Alain Cantagrel France
Roberto Caporali Italy
Solbritt Rantapää‐Dahlqvist Sweden
Gianfranco Ferraccioli Italy
M. A. van Leeuwen Netherlands View profile →
Citations per field, relative to F. C. Breedveld
F. C. Breedveld · 1×
Citations per year, relative to F. C. Breedveld
F. C. Breedveld · 1×

Countries citing papers authored by F. C. Breedveld

Since Specialization
Citations

This map shows the geographic impact of F. C. Breedveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. C. Breedveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. C. Breedveld more than expected).

Fields of papers citing papers by F. C. Breedveld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. C. Breedveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. C. Breedveld. The network helps show where F. C. Breedveld may publish in the future.

Co-authorship network of co-authors of F. C. Breedveld

This figure shows the co-authorship network connecting the top 25 collaborators of F. C. Breedveld. A scholar is included among the top collaborators of F. C. Breedveld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. C. Breedveld. F. C. Breedveld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Long-Term Impact of Delaying Combination Therapy With Adalimumab Plus Methotrexate By 2 Years in Patients With Early Rheumatoid Arthritis: Final 10-Year Results of the Premier Trial
1
2
Initial Combination Therapy with Adalimumab Plus Methotrexate Leads to Better Long-Term Outcomes Than with Either Monotherapy in Patients with Early Rheumatoid Arthritis: 8-Year Results of An Open-Label Extension of a Phase 3 Trial
5
3 116
4 102
5 11
6
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial breakdown →
1104
7 112
8 119
9
Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
440
10 18
11 30
12 116
13 54
14
TREATMENT OF RHEUMATOID-ARTHRITIS WITH ANTIBODY TO TNF-ALPHA DECREASES EXPRESSION AND SHEDDING OF E-SELECTIN
1
15
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis breakdown →
1339
16 1
17 41
18 68
19 37
20 12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026